KHIRON LIFE SCIENCES WKN: A2JMZC ISIN: CA49374L3065 Kürzel: 4KH Forum: Aktien Thema: Hauptdiskussion

Einfach aussitzen.

Schön -55%

Dann hoffen wir einmal dass endlich mal wieder dauerhaft gen Süden geht....

https://www.newswire.ca/news-releases/khiron-boosts-european-expansion-with-key-executive-appointments-888908962.html

Auf nach Europa!

https://investors.khiron.ca/press-releases/detail/106/khiron-signs-kuida-distribution-agreement-with-grupo

TORONTO and DENVER, Aug. 6, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, and Dixie Brands Inc. ("Dixie") (CSE: DIXI.U), (OTCQX: DXBRF), (Frankfurt: 0QV), one of the cannabis industry's leading consumer packaged goods companies, announced today that their previously disclosed 50/50 Joint Venture ("JV") has received conditional approval from the TSX Venture Exchange ("TSXV"), subject to receipt of customary closing documentation. With this approval in place, Khiron and Dixie will begin the process of commercialization of the Kuida cosmeceutical product *** in the U.S. marketplace, as well as the introduction of Dixie's CBD-infused products into Latin America. Through the JV, Dixie will be responsible for the distribution of Khiron's portfolio of Kuida cosmeceutical products in the U.S. Kuida products will be broadly distributed through Dixie's established distribution network to U.S. consumers, and are expected to have particular appeal to the growing U.S. Hispanic population, estimated at nearly 60 million. Further, the conditional TSXV approval allows for the manufacture and commercialization of Dixie's products in Latin America, leveraging Khiron's legislative, sales and marketing abilities and Dixie's extensive and market-proven product ***. It is anticipated that Dixie CBD-based products will be commercialized in Latin America beginning in 2020. The JV also creates a framework for the development of new products and brands tailored to Latin America, allowing Dixie and Khiron to take full advantage of opportunities resulting from advancements in cannabis legalization in the region. The conditional TSXV approval covers operations in Colombia, Chile and Uruguay; additional applications will be *** to the TSXV as more Latin American countries legalize the use of cannabis.

https://themazatlanpost.com/2019/07/26/mexico-recreational-use-of-marijuana-will-be-addressed-in-september-in-the-senate/?fbclid=IwAR2WwVyvZ1-P73Aasw-UOJ9Y9BEHLzNzeUozpE-sikfA1UBkEmFPhas-mfM

https://youtu.be/fBxMgakfgjs

Omg, S@au und D@umm werden hier zensiert. Wo leben wir, George Orwell? Doppel Plus gut oder was?

Ach ja, Khiron und News....ich denke da immer, nur bloss keine News. Khiron hat meinen ganzen Jahresschnittversaut, von einem ganzem Portfolio (50% crash vom EK)! Kann man ansonsten schön reden wie man will, die Performance ist aktuell unter aller ***. Naja, ich halte die aber bis entweder wieder über meinem Ek (womit zu rechnen ist) oder bis zur Insolvenz. Also Leute, nur keine Angst. Frust ist erlaubt, aber KEINE voreiligen Verkäufe. Das wäre ***.

Dixi macht sein Zeug. Könnte Khiron profitieren

TORONTO, July 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that it has been added to The Cannabis ETF (NYSE: THCX) ("THCX"), which trades on the New York Stock Exchange. THCX seeks to track the Innovation Labs Cannabis Index, which is a portfolio of 35 stocks expected to benefit from growth of the legal marijuana, CBD and hemp industries. Alvaro Torres, CEO and a Director of Khiron, comments. "We are pleased to be included in The Cannabis ETF index which increases our exposure to U.S. investors, and provides an important opportunity to articulate our vision as a global cannabis company based in Latin America."

https://midasletter.com/2019/07/iconic-entrepreneur-joe-mimran-excited-by-khiron-life-sciences-corp-cvekhrn/

Unabhängig vom Absatzmarkt würde in der Dokumentation bestimmt nicht gesagt dass man bei einer Expansion erstmal Geld in die Hand nehmen muss und jede Erweiterung und unbekannte Absatzmärkte birgt auch ein hohes Risiko. Aber ich hoffe mal auf Mango dass Khiron den nächsten Schritt macht und zumindest in Süd- und Mittelamerika richtungsweisend sein wird.

Khiron ist aber nicht wirklich EU! Hauptzweig Kolumbien und hoffen bald Mexiko usw.